Oral Session 3-8B ATL: Treatment

[OS3-8B-2] VCAP-AMP-VECP versus CHOP for aggressive adult T-cell leukemia-lymphoma: a propensity score analysis

Shigeo Fuji^1,2, Takuhiro Yamaguchi³, Yoshitaka Inoue⁴, Atae Utsunomiya⁵, Yukiyoshi Moriuchi⁶, Satsuki Owatari⁷, Takashi Miyagi⁸, Yasushi Sawayama⁹, Eiichi Ohtsuka¹⁰, Shinichiro Yoshida¹¹, Takahiro Fukuda² (1.Hematology, Osaka International Cancer Institute, Osaka, Japan, 2.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 3.Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan, 4.Hematology, Kumamoto University Hospital, Kumamoto, Japan, 5.Hematology, Imamura General Hospital, Kagoshima, Japan, 6.Hematology, Sasebo City General Hospital, Sasebo, Japan, 7.Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan, 8.Hematology, Heart-Life Hospital, Okinawa, Japan, 9.Hematology, Nagasaki University Hospital, Nagasaki, Japan, 10.Hematology, Oita Prefectural Hospital, Oita, Japan, 11.Hematology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan)